News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
MILESON GLENNA
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/23/2023 |
4
| MILESON GLENNA (CFO) has filed a Form 4 on Athira Pharma, Inc.|
Txns:
| Granted 150,000 options to buy
@ $3.37, valued at
$505.5k
|
|
| 12/30/2022 |
4
| MILESON GLENNA (CFO) has filed a Form 4 on Athira Pharma, Inc.|
Txns:
| Granted 763 shares
@ $2.74, valued at
$2.1k
Bought 50,000 shares
@ $2.845, valued at
$142.3k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/12/2022 |
4
| MILESON GLENNA (CFO) has filed a Form 4 on Athira Pharma, Inc.|
Txns:
| Exercised 3,000 options to buy
@ $10.64, valued at
$31.9k
|
|
| 01/20/2022 |
4
| MILESON GLENNA (CFO) has filed a Form 4 on Athira Pharma, Inc.|
Txns:
| Granted 170,000 options to buy
@ $10.64, valued at
$1.8M
|
|
| 01/06/2022 |
4
| MILESON GLENNA (CFO) has filed a Form 4 on Athira Pharma, Inc.|
Txns:
| Granted 931 shares
@ $12.51, valued at
$11.6k
Exercised 6,305 options to buy
@ $1.35, valued at
$8.5k
|
|
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|